AbbVie 2012 Annual Report Download - page 108

Download and view the complete annual report

Please find page 108 of the 2012 AbbVie annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 200

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199
  • 200

Exhibit
Number Exhibit Description
10.6 *International Commercial Operations Agreement by and between Abbott Laboratories and
AbbVie Inc. (incorporated by reference to Exhibit 10.6 of the Company’s Current Report on
Form 8-K filed on January 2, 2013).
10.7 *Luxembourg International Commercial Operations Agreement by and between Abbott
Investments Luxembourg S.`
ar.l. and AbbVie Investments S.`
ar.l. (incorporated by reference to
Exhibit 10.7 of the Company’s Current Report on Form 8-K filed on January 2, 2013).
10.8 *Information Technology Agreement by and between Abbott Laboratories and AbbVie Inc.
(incorporated by reference to Exhibit 10.8 of the Company’s Current Report on Form 8-K
filed on January 2, 2013).
10.9 *Transitional Trademark License Agreement by and between Abbott Laboratories and
AbbVie Inc. (incorporated by reference to Exhibit 10.9 of the Company’s Current Report on
Form 8-K filed on January 2, 2013).
10.10 *Form of Finished Goods Supply Agreements by and between Abbott Laboratories and
AbbVie Inc. (incorporated by reference to Exhibit 10.11 of Amendment No. 2 to the
Company’s Registration Statement on Form 10 filed on September 4, 2012).
10.11 *Form of Contract Manufacturing Agreements by and between Abbott Laboratories and
AbbVie Inc. (incorporated by reference to Exhibit 10.12 of Amendment No. 2 to the
Company’s Registration Statement on Form 10 filed on September 4, 2012).
10.12 *Form of Agreement Regarding Change in Control (incorporated by reference to
Exhibit 10.13 of Amendment No. 5 to the Company’s Registration Statement on Form 10 filed
on November 16, 2012).**
10.13 *AbbVie 2013 Incentive Stock Program (incorporated by reference to Exhibit 10.14 of
Amendment No. 6 to the Company’s Registration Statement on Form 10 filed on
November 30, 2012).**
10.14 AbbVie 2013 Management Incentive Plan.**
10.15 AbbVie 2013 Performance Incentive Plan.**
10.16 AbbVie Deferred Compensation Plan.**
10.17 AbbVie Non-Employee Directors’ Fee Plan.**
10.18 AbbVie Supplemental Pension Plan.**
10.19 AbbVie Supplemental Savings Plan.**
10.20 *Purchase Agreement dated November 5, 2012 between AbbVie Inc., Abbott Laboratories, as
guarantor, and Morgan Stanley & Co. LLC, Barclays Capital Inc., J.P. Morgan Securities LLC,
and Merrill Lynch, Pierce, Fenner & Smith Incorporated (incorporated by reference to
Exhibit 10.21 of Amendment No. 6 to the Company’s Registration Statement on Form 10 filed
on November 30, 2012).
21.1 Subsidiaries of AbbVie Inc.
23.1 Consent of Independent Registered Public Accounting Firm.
31.1 Certification of Chief Executive Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).
31.2 Certification of Chief Financial Officer Required by Rule 13a-14(a) (17 CFR 240.13a-14(a)).
102